In this piece, “Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders,” Nick, Mike, and Ben provide an overview of the disorders’ clinical features and the current understanding of pathogenic mechanisms and therapeutic development.
